Finance

Lists
Why is CUE down 3,86%?
Dive Deeper
CUE:NASDAQ
Cue Biopharma Inc
19,08 USD
-3,86%
(-0,76) 1D
5-ноя., 09:58:04 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CUE...
Open
19,35 USD
High
19,74 USD
Low
18,77 USD
Mkt. cap
138,57 млн
Avg. vol.
181,70 миң
Volume
8,09 миң
52-wk high
45,50 USD
52-wk low
4,97 USD
EPS
-26,99 USD
Beta
2,79
Shares outstanding
7,26 млн
No. of employees
29
Open
19,35 USD
High
19,74 USD
Low
18,77 USD
Mkt. cap
138,57 млн
Avg. vol.
181,70 миң
Volume
8,09 миң
52-wk high
45,50 USD
52-wk low
4,97 USD
EPS
-26,99 USD
Beta
2,79
Shares outstanding
7,26 млн
No. of employees
29
News stories
From web sources and news partners
About Cue Biopharma Inc
CEO-
Employees29
Founded2014
HeadquartersБостон, Массачусетс, Америка Кошмо Штаттары
Sector-
Industry-
Websitecuebiopharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to CUE in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CUE in the last 3 months
Highest
Current 19,08 USD
83,00 USD (+335,12%)
Average
83,00 USD (+335,12%)
Lowest
83,00 USD (+335,12%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mayank Mamtani
B. Riley Securities
Buy
Initiated
83,00 USD
+335,1%
09/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
2,15 млн
21,94 млн
5,69 млн
7,88 млн
Cost of goods sold
4,15 млн
15,93 млн
6,40 млн
48,51 млн
Cost of revenue
4,15 млн
15,93 млн
6,40 млн
48,51 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,54 млн
4,05 млн
4,65 млн
47,06 млн
Operating expense
5,54 млн
4,05 млн
4,65 млн
47,06 млн
Total operating expenses
9,69 млн
19,98 млн
11,05 млн
95,57 млн
Operating income
-7,54 млн
1,96 млн
-5,36 млн
-87,70 млн
Other non operating income
-
-
-
-65,52 млн
EBT including unusual items
-7,45 млн
2,08 млн
-5,18 млн
-153,07 млн
EBT excluding unusual items
-7,40 млн
2,06 млн
-5,19 млн
-153,07 млн
Income tax expense
-
500,00 миң
-
-
Effective tax rate
-
23,98%
-
-
Other operating expenses
-
-
-
-
Net income
-7,45 млн
1,58 млн
-5,18 млн
-153,07 млн
Net profit margin
-346,58%
7,22%
-91,07%
-1 943,21%
Earnings per share
-2,10
-
-
-
Interest and investment income
222,00 миң
158,00 миң
179,00 миң
157,00 миң
Interest expense
-75,00 миң
-51,00 миң
-4,00 миң
-5,00 миң
Net interest expenses
147,00 миң
107,00 миң
175,00 миң
152,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-7,46 млн
2,64 млн
-4,80 млн
-87,66 млн
Gain or loss from assets sale
51,00 миң
-20,00 миң
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору